STAT January 21, 2025
And other musts-read biotech news stories.
Another day, another president. Good morning! Today, we hear from former FDA officials, who lay out what they think the agency will need to thrive under the new Trump administration. We learn more about the scope of effect of GLP-1s, and see a new antibody-drug conjugate approved. Plus, radiopharmaceuticals!
FDA alums offer roadmap for the Trump administration
President Trump’s new administration will likely bring major changes at the FDA, with nominees like Robert F. Kennedy...
Today's Sponsors
Today's Sponsor